Llerena K

Translational Psychedelic Research Program, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco.

2 papers · ORCID

ArticlePsilocybin

An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.

Downey AE, Szigeti B, Bradley ER +11

Europe PMC2026

ArticlePsilocybin

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.

Bradley ER, Sakai K, Fernandes-Osterhold G +15

Europe PMC2025